Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :30326595
Publication Date : //

Targeting of FGF-Signaling Re-Sensitizes Gastrointestinal Stromal Tumors (GIST) to Imatinib In Vitro and In Vivo.


Dysregulation of the fibroblast growth factor (FGF)/fibroblast growth factor receptor (FGFR) signaling pathway is frequently observed in multiple human malignancies, and thus, therapeutic strategies targeting FGFs and FGFRs in human cancer are being extensively explored. We observed the activation of the FGF/FGFR-signaling pathway in imatinib (IM)-resistant gastrointestinal stromal tumor (GIST) cells. Furthermore, we found that the activation of FGFR signaling has a significant impact on IM resistance in GISTs in vitro. Next, we tested the efficacy of BGJ398, a potent and selective FGFR1⁻3 inhibitor, in xenograft models of GISTs exhibiting secondary IM resistance due to receptor-tyrosine kinase (RTK) switch (loss of c-KIT/gain of FGFR2a). Five to eight-week-old female nu/nu mice were subcutaneously inoculated into the flank areas with GIST T-1R cells. Mice were randomized as control (untreated), IM, BGJ398, or a combination and treated orally for 12 days. IM had a moderate effect on tumor size, thus revealing GIST resistance to IM. Similarly, a minor regression in tumor size was observed in BGJ398-treated mice. Strikingly, a 90% decrease in tumor size was observed in mice treated with a combination of IM and BGJ398. Treatment with BGJ398 and IM also induced major histopathologic changes according to a previously defined histopathologic response score and resulted in massive myxoid degeneration. This was associated with increased intratumoral apoptosis as detected by immunohistochemical staining for cleaved caspase-3 on day 5 of the treatment. Furthermore, treatment with BGJ398 and IM significantly reduced the proliferative activity of tumor cells as measured by positivity for Ki-67 staining. In conclusion, inhibition of FGFR signaling substantially inhibited the growth of IM-resistant GISTs in vitro and showed potent antitumor activity in an IM-resistant GIST model via the inhibition of proliferation, tumor growth, and the induction of apoptosis, thereby suggesting that patients with advanced and metastatic GISTs exhibiting IM resistance might benefit from therapeutic inhibition of FGFR signaling.

Authors : Boichuk Sergei , Galembikova Aigul , Dunaev Pavel , Micheeva Ekaterina , Valeeva Elena , Novikova Maria , Khromova Natalya , Kopnin Pavel ,

Related products :

Catalog number Product name Quantity
GIST481 Gastrointestinal stromal tumor (GIST) tissue array, 24 cases, 48 samples (2mm) 24 Cases
GIST801 Gastrointestinal stromal tumor (GIST) tissue array, 80 cases_80 cores
GIST801 Gastrointestinal stromal tumor (GIST) tissue array, 80 cases_80 cores; ihc Anti-Actin confirmed
GIST481 Gastrointestinal stromal tumor (GIST) tissue array, 24 cases, 48 samples (2mm) Species Human Anatomic System Digestive system 2 mm
SL100500 Transfection Reagents and Kits,GenJet™ Plus DNA In Vivo Tranfection Reagent was formulated from its in vitro version to effectively deliver DNA in vivo. 0,1 ml
SL100500 Transfection Reagents and Kits,GenJet™ Plus DNA In Vivo Tranfection Reagent was formulated from its in vitro version to effectively deliver DNA in vivo. 1 ml
SL100500 Transfection Reagents and Kits,GenJet™ Plus DNA In Vivo Tranfection Reagent was formulated from its in vitro version to effectively deliver DNA in vivo. 0,5 ml
Gl_GIST481 GIST array consists of 24 duplcated cases of gastrointestinal stroma tumor with various grades and stages. 2mm
6357 SR-VAD-OPH in vitro and in vivo Apoptosis Detection Reagent Pack of 4 Vials
6355 FAM-VAD-OPH II in vitro and in vivo Apoptosis Detection Reagent Pack of 4 Vials
6354 FAM-VAD-OPH I in vitro and in vivo Apoptosis Detection Reagent Pack of 4 Vials
6356 FAM-DEVD-OPH in vitro and in vivo Apoptosis Detection Reagent Pack of 4 Vials
DG-1001 CyAL-5 2-Deoxyglucose,fluorescent imaging agent for target of cancers such as breast, glioblastoma, colon and prostate in vitro and in vivo
GIST481-1 Gastrointestinal Stromal Tumor tissue array 1x (6x8)
GIST481-1 Gastrointestinal Stromal Tumor tissue array 1x (6x8)
GIST481-5 Gastrointestinal Stromal Tumor tissue array 5x (6x8)
GIST481-5 Gastrointestinal Stromal Tumor tissue array 5x (6x8)
'GIST481-5 Gastrointestinal Stromal Tumor tissue array tissues 5x (6x8)
'GIST481-1 Gastrointestinal Stromal Tumor tissue array tissues 1x (6x8)
PTGA225 Tissue microarrays, AccuMaxTM, Gastrointestinal stromal tumor tissues slide
GIST481 Gastrointestinal stromal tumor tissue array, 24 cases_48 cores
orb61347 Masitinib Masitinib mesylate (AB1010) is a protein tyrosine kinase inhibitor. In vitro it has greater activity and selectivity than imatinib mesylate against the wild-type c-Kit receptor and the mutat 100 mg
25-430 KLF11 (TIEG2) is a pancreas-enriched transcription factor that has elicited significant attention because of its role as negative regulator of exocrine cell growth in vitro and in vivo. It plays a rol 0.05 mg
27-275 KLF11 (TIEG2) is a pancreas-enriched transcription factor that has elicited significant attention because of its role as negative regulator of exocrine cell growth in vitro and in vivo. It plays a rol 0.1 mg
M0612 MarkerGeneTM Fluorescent Lipase Assay Kit, Allows fast and easy measurement of lipase activity in vitro, in cell preparations or in vivo, 1 kit


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur